Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Medicare Bill Directs GAO To Study International Price Controls

Executive Summary

The Senate Medicare legislation would direct the General Accounting Office to produce a study of international price controls within one year of enactment
Advertisement

Related Content

Medicare Law Puts Rx In Spotlight Of Presidential Campaign Politics
FDA Efficacy Standard Is Target Of WLF Suit; “Tiered” Approvals Proposed
Rx Cost-Effectiveness Studies Should Be Part Of Medicare Bill, AARP Says
Medicare Rx Conference Could Last Into Fall; AWP One Sticking Point
Medicare Bills Head To Conference: Senate Earns Broader Bipartisan Support
Medicare Bills Head To Conference: Senate Earns Broader Bipartisan Support
Medicare Rx Law Would Fundamentally Change, Not End, Drug Pricing Debate
NIH Hypertension Guidelines Suggest Newer Agents For Certain Risk Factors
Generic Drug Reforms: FTC Notification Bill Appears Ready To Move In 2003
Medicare Rx Block Grant Approach Viewed Skeptically By Penn. Gov. Ridge
Advertisement
UsernamePublicRestriction

Register

PS042106

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel